Curtis v. Inslee

CourtDistrict Court, W.D. Washington
DecidedDecember 21, 2023
Docket3:23-cv-05741
StatusUnknown

This text of Curtis v. Inslee (Curtis v. Inslee) is published on Counsel Stack Legal Research, covering District Court, W.D. Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Curtis v. Inslee, (W.D. Wash. 2023).

Opinion

1 2 3 4 5

6 7 UNITED STATES DISTRICT COURT 8 WESTERN DISTRICT OF WASHINGTON AT TACOMA 9 10 AILA CURTIS, et al., CASE NO. 3:23-cv-05741-RJB 11 Plaintiffs, ORDER GRANTING DEFENDANT 12 v. INSLEE’S MOTION TO DISMISS 13 JAY ROBERT INSLEE, PEACEHEALTH, LIZ DUNNE, DOUG KOEKKOEK, 14 Defendants. 15

16 This matter comes before the Court on Washington State Governor Jay Robert Inslee’s 17 Motion to Dismiss. Dkt. 18. The Court has considered the pleadings filed regarding the motion 18 and the file herein. 19 This case arises from Defendants’ COVID-19 vaccine mandates for healthcare workers. 20 Dkt. 8. Gov. Inslee moves the Court to take judicial notice of certain facts and moves to dismiss 21 the claims against him pursuant to Fed. R. Civ. P. (“Rule”) 12(b)(6). Dkt. 18. For the reasons 22 provided below, the motions (Dkt. 18) should be granted. 23 24 1 I. MOTION FOR JUDICIAL NOTICE, FACTS AND PROCEDURAL HISTORY 2 A. SOURCES OF THE FACTS TO BE CONSIDERED ON THE MOTION TO DISMISS AND GOV. INSLEE’S MOTION FOR JUDICIAL NOTICE 3 When evaluating the sufficiency of a pleading under Rule 12(b)(6), a court reviews the 4 allegations in the complaint and any attachments or documents incorporated by reference. Koala 5 v. Khosla, 931 F.3d 887, 894 (9th Cir. 2019). “Certain written instruments attached to pleadings 6 may be considered part of the pleading. Even if a document is not attached to a complaint, it 7 may be incorporated by reference into a complaint it the plaintiff refers extensively to the 8 document or the document forms the basis of the plaintiff’s claim.” United States v. Ritchie, 342 9 F.3d 903, 908 (9th Cir. 2003). 10 Although for purposes of a motion to amend or for a motion to dismiss the court ordinarily 11 credits the allegations in the complaint as true, it need not “accept as true allegations that 12 contradict matters properly subject to judicial notice,” or in a complaint’s attachment, or 13 incorporated by reference into the complaint. Gonzalez v. Planned Parenthood of Los Angeles, 14 759 F.3d 1112, 1115 (9th Cir. 2014); Steckman v. Hart Brewing, Inc., 143 F.3d 1293, 1295-96 15 (9th Cir. 1998)(the court is “not required to accept as true conclusory allegations which are 16 contradicted by documents referred to in the complaint”). 17 Pursuant to Federal Rule of Evidence 201(b): “[t]he court may judicially notice a fact that 18 is not subject to reasonable dispute because it: (1) is generally known within the trial court’s 19 territorial jurisdiction; or (2) can be accurately and readily determined from sources whose 20 accuracy cannot be reasonably questioned.” 21 The facts are taken from the Amended Complaint, its attachments, and facts subject to 22 judicial notice. Where judicial notice is taken, it will be designated. Additionally, some general 23 background information will be taken from court decisions. 24 1 B. BACKGROUND FACTS 2 1. COVID-19, Emergency Use Authorizations for Vaccines, and Vaccine Program 3 COVID–19 is a “highly contagious, dangerous, and . . . deadly disease.” Biden v. 4 Missouri, 595 U.S. 87, 93 (2022). The COVID-19 pandemic posed significant challenges for 5 federal and state governments. Dkt. 8. Beginning in February of 2020, Gov. Inslee declared a

6 state of emergency and issued several public health and safety proclamations. Flower World, 7 Inc. v. Sacks, 43 F.4th 1224, 1227 (9th Cir. 2022). 8 In December of 2020, the Federal Drug Administration (“FDA”) granted emergency use 9 authorization (“EAU”) for the Pfizer-BioNTech (“Pfizer-BioNTech”) two-dose mRNA vaccine 10 for individuals 16 and older and for the Moderna two-dose mRNA vaccine for individuals 18 11 years and older. Dkt. 8. On December 21, 2020, Pfizer-BioNTech received conditional 12 marketing authorization in the European Union (“EU”) for its COVID-19 vaccine, marketed as 13 COMIRNATY®. Id. On February 27, 2021, the FDA granted EAU for the Johnson & Johnson 14 vaccine for individuals 18 and older. Id.

15 The Amended Complaint alleges that Gov. Inslee voluntarily agreed to participate in the 16 Center for Disease Control and Prevention’s (“CDC”) COVID-19 Vaccination Program. Dkt. 8 17 at 20. It further contends that “[a]lthough the CDC states that Defendants are engaged in a 18 ‘Vaccination Program,’ the CDC has relied exclusively on investigational drugs to administer its 19 COVID-19 Vaccination Program Provider Agreement (“Provider Agreement), which means no 20 one has received a true vaccine against any COVID-19 virus.” Id. 21 Even after vaccines became available, the pandemic continued, with the virus mutating 22 into various strains. Does 1-6 v. Mills, 16 F.4th 20, 26 (1st Cir. 2021), cert. denied sub nom. 23 Does 1-3 v. Mills, 142 S. Ct. 1112 (2022). In the United States, the summer of 2021 saw the 24 1 emergence of a highly contagious COVID variant referred to as the “Delta” variant. Id. COVID 2 cases, hospitalizations and deaths rose sharply. CDC, COVID Data Tracker, 3 https://covid.cdc.gov/covid-data-tracker/#trends_weeklyhospitaladmissions_select_00 (last 4 visited December 13, 2023); https://covid.cdc.gov/covid-data- 5 tracker/#trends_weeklydeaths_select_00 (last visited December 13, 2023).

6 2. Gov. Inslee’s Proclamation, Approval of Pfizer-BioNTech Vaccine, PeaceHealth’s Policy, and Federal Government’s Rule 7 On August 20, 2021, Gov. Inslee issued Proclamation 21-14.1, “Covid-19 Vaccination 8 Requirement,” (“Proclamation”) which required state workers, workers in an education setting, 9 and healthcare providers to be fully vaccinated by October 18, 2021, unless they qualified for 10 medical or religious exemptions. Dkt. 8-7. 11 On August 23, 2021, the Pfizer-BioNTech vaccine, COMIRNATY®, received full approval 12 for individuals 16 and older. FDA Approval Letter (August 23, 2021), 13 http://www.fda.gov/media/151710/download (last visited December 13, 2023); FDA News 14 Release (August 23, 2021), https://www.fda.gov/news-events/press-announcements/fda- 15 approves-first-covid-19-vaccine (last visited December 13, 2023). 16 The Plaintiffs’ Amended Complaint maintains that the Pfizer-BioNTech vaccine was not 17 fully approved in August of 2021 and so was, and still is, “experimental.” Dkt. 8. This 18 contention was considered and rejected by the court in Johnson v. Brown, 567 F. Supp. 3d 1230, 19 1241 (D. Or. 2021), is belied by the FDA’s approval of COMIRNATY®, and the CDC’s later 20 explanation, which provided: 21 Pfizer-BioNTech (COMIRNATY®) received U.S. Food and Drug Administration 22 (FDA) approval on August 23, 2021, for individuals 16 years of age and older. Once vaccines are approved by the FDA, companies can market the vaccines 23 under brand names. COMIRNATY® is the brand name for the Pfizer-BioNTech COVID-19 Vaccine. Now that the FDA-authorized Pfizer-BioNTech COVID-19 24 1 vaccine has been approved by the FDA for individuals 16 years of age and older, it will be marketed as COMIRNATY®. The use of the name Pfizer-BioNTech 2 will still be used for individuals 12-15 years old since this age group has not been approved. There has been no change in the formulation of the vaccine since the 3 name change.

4 Pfizer-BioNTech COVID-19 Vaccine Overview and Safety (also known as COMIRNATY®), Ctrs 5 For Disease Control & Prevention (Oct. 28, 2021), https://stacks.cdc.gov/view/cdc/111109 6 (emphasis in original) (last visited December 13, 2023). 7 In light of the FDA’s actions and the CDC’s explanation, Governor Inslee’s motion for 8 the Court to take judicial notice that the Pfizer-BioNTech vaccine was approved on August 23, 9 2021 (Dkt. 18) should be granted. The Pfizer-BioNTech vaccine received approval on August 10 23, 2021. We The Patriots USA, Inc. v. Hochul, 17 F.4th 266, 283 (2d Cir.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jacobson v. Massachusetts
197 U.S. 11 (Supreme Court, 1905)
Ex Parte Young
209 U.S. 123 (Supreme Court, 1908)
Parratt v. Taylor
451 U.S. 527 (Supreme Court, 1981)
Harlow v. Fitzgerald
457 U.S. 800 (Supreme Court, 1982)
Daniels v. Williams
474 U.S. 327 (Supreme Court, 1986)
United States v. Lanier
520 U.S. 259 (Supreme Court, 1997)
Sosa v. Alvarez-Machain
542 U.S. 692 (Supreme Court, 2004)
Brosseau v. Haugen
543 U.S. 194 (Supreme Court, 2004)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Pearson v. Callahan
555 U.S. 223 (Supreme Court, 2009)
Wolfe v. Strankman
392 F.3d 358 (Ninth Circuit, 2004)
Wilkinson v. Austin
545 U.S. 209 (Supreme Court, 2005)
Michael Lacey v. Joseph Arpaio
693 F.3d 896 (Ninth Circuit, 2012)
Koontz v. St. Johns River Water Management Dist.
133 S. Ct. 2586 (Supreme Court, 2013)
Doe v. Rumsfeld
297 F. Supp. 2d 119 (District of Columbia, 2003)
Wright v. Fred Hutchinson Cancer Research Center
269 F. Supp. 2d 1286 (W.D. Washington, 2002)
Alexander v. Sandoval
532 U.S. 275 (Supreme Court, 2001)
P. Victor Gonzalez v. Planned Parenthood of La
759 F.3d 1112 (Ninth Circuit, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Curtis v. Inslee, Counsel Stack Legal Research, https://law.counselstack.com/opinion/curtis-v-inslee-wawd-2023.